SURVYR

iShares Biotechnology ETF (IBB)
As of Jun 30, 2026, filed Aug 25, 2026. Holdings may be out of date: funds report them to the SEC quarterly, with a lag.SEC filing ↗All ETF tools

IBB holds 248 positions; the top 10 are 44.7% of the fund. The largest is Vertex Pharmaceuticals, Inc. at 8.1%. Biggest sector: Health Care (47%).

Largest holding
8.1%
VRTX
Top 10 holdings
44.7%
of the fund
Holdings
248
net assets $9.1B
Biggest sector
47%
Health Care

Top 25 holdings

Largest first, as a share of the fund. Tap a stock for its SURVYR. page.

#Holding% of fund
1Vertex Pharmaceuticals, Inc.VRTX · Health Care8.08%
2Amgen, Inc.AMGN · Health Care7.83%
3Gilead Sciences, Inc.GILD · Health Care6.84%
4Regeneron Pharmaceuticals, Inc.REGN · Health Care4.91%
5Argenx SEARGX · Healthcare3.76%
6
Alnylam Pharmaceuticals, Inc.ALNY
3.12%
7Natera, Inc.NTRA · Healthcare2.89%
8Revolution Medicines, Inc.RVMD · Healthcare2.78%
9Biogen, Inc.BIIB · Health Care2.47%
10Illumina, Inc.ILMN · Health Care2.07%
11Moderna, Inc.MRNA · Health Care1.98%
12Insmed, Inc.INSM · Biotech & Healthcare1.78%
13
BeOne Medicines Ltd.ONC
1.77%
14Incyte Corp.INCY · Health Care1.75%
15United Therapeutics Corp.UTHR · Health Care1.73%
16Roivant Sciences Ltd.ROIV · Health Care1.43%
17Neurocrine Biosciences, Inc.NBIX · Health Care1.30%
18
Ascendis Pharma A/SASND
1.29%
19Genmab A/SGMAB · Healthcare1.12%
20Exelixis, Inc.EXEL · Health Care1.03%
21Ionis Pharmaceuticals, Inc.IONS · Healthcare1.00%
22Bridgebio Pharma, Inc.BBIO · Healthcare0.98%
23Medpace Holdings, Inc.MEDP · Health Care0.95%
24Madrigal Pharmaceuticals, Inc.MDGL0.91%
25Bio-Techne Corp.TECH · Health Care0.86%

Top 25 of 248 holdings by weight. Full list on SEC ↗ · All SEC filings

Cash and derivatives

Grouped, not listed one by one. Futures and swaps count at their gain or loss, not their full exposure.

Cash and money market2 lines12.04%
Futures, swaps and options1 line0.00%

Sectors

Share of the fund in each sector; holdings we can’t match are in “Other / unmapped”.

Health Care 52.5%Healthcare 24.9%Biotech & Healthcare 1.8%Other / unmapped 20.7%Cash 12.0% 47%Health Care
Health Care52.5%
Healthcare24.9%
Biotech & Healthcare1.8%
Other / unmapped20.7%
Cash12.0%

Overlap with SURVYR. portfolios

How much of IBB, by weight, is in stocks each portfolio holds today.

SURVYR. Long Book6.8%
3 of its 28 stocks are in IBB (ARGX, RVMD, BEAM). 10% of the portfolio is in IBB names.
Quality Growth1.7%
1 of its 15 stocks are in IBB (INCY). 7% of the portfolio is in IBB names.
Momentum Top 152.0%
1 of its 15 stocks are in IBB (MRNA). 7% of the portfolio is in IBB names.
Momentum Blend2.0%
1 of its 21 stocks are in IBB (MRNA). 5% of the portfolio is in IBB names.
New Highs Growth5.7%
7 of its 25 stocks are in IBB (RVMD, ROIV, PRAX, CGON, RLAY…). 28% of the portfolio is in IBB names.
SURVYR. Barbell Momentum & T-Bill Shield1.8%
1 of its 16 stocks are in IBB (INSM). 5% of the portfolio is in IBB names.
SURVYR. Physical AI Grid & Power0.0%
No shared holdings.

Compare

Compare IBB with SPY or other funds: costs, past returns and shared holdings. IBB price chart · Compare stocks instead

How this works & disclosures

Source: iShares Biotechnology ETF’s Form NPORT-P for the period ending Jun 30, 2026, filed with the SEC on Aug 25, 2026. Weights are each holding’s value as a share of the fund’s net assets on that date; cash, futures and swaps are grouped. Tickers and sectors are matched by SURVYR. and may be missing for some holdings. Overlap with SURVYR. portfolios is the share of the fund, by weight, in stocks each portfolio holds today.

Data from SEC Form N-PORT, the holdings report funds file with the SEC each quarter; the SEC makes it public about 60 days after the quarter ends. Holdings change; this may be out of date. SURVYR. describes what funds hold and how they have done; it does not manage money or give advice. Not investment advice. Full disclosures

Data from SEC filings. Holdings change; this may be out of date. Not investment advice. Disclosures

Morning Brief (8 AM ET) & Market Close (4:30 PM ET), weekdays

Indexes, sectors, biggest movers, rates, top news, SURVYR. model changes and what's ahead. Free, two short emails each weekday.

Editions

Free. Not investment advice. Unsubscribe anytime.

SURVYR

Free to use. No card, no ads, no auto-renew.

Systematic research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app

How it worksOur promiseTermsPrivacyData statusSend feedback
Coteau 0.9 · Oct 21, 2026